Plasma osteopontin concentrations in patients with cutaneous melanoma

An effective circulating tumour marker is needed for melanoma especially with the advent of targeted therapies. Gene expression studies examining primary melanomas have shown that increased expression of osteopontin (SPP1) is associated with poor prognosis. Studies subsequently reported higher blood...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: FILIA, A., ELLIOTT, F., WIND, T., FIELD, S., DAVIES, J., KUKALIZCH, K., RANDERSON-MOOR, J., HARLAND, M., BISHOP, D.T., BANKS, R.E., NEWTON-BISHOP, J.A.
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2013
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3810214/
https://ncbi.nlm.nih.gov/pubmed/23934016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2013.2666
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires